Iwona Pałyga Selected Research

DNA (Deoxyribonucleic Acid)

9/2017	Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma.
8/2017	The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iwona Pałyga Research Topics

Disease

6	Neoplasms (Cancer) 05/2021 - 08/2015
6	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2006
4	Papillary Thyroid Cancer 10/2019 - 08/2017
3	Neoplasm Metastasis (Metastasis) 10/2019 - 09/2010
1	Lymphatic Metastasis 05/2021
1	medullary Thyroid cancer 01/2021
1	Necrosis 01/2020
1	Disease Progression 10/2019

Drug/Important Bio-Agent (IBA)

3	Thyroglobulin FDA Link 01/2020 - 01/2006
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021 - 09/2010
2	prolinedithiocarbamate (PDTC)IBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 08/2017
2	Thyrotropin Alfa FDA LinkGeneric 01/2015 - 01/2006
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	IodineIBA 10/2017
1	Phosphotransferases (Kinase)IBA 08/2015
1	Gallium-68IBA 09/2010
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2010
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 09/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2006

Therapy/Procedure

4	Therapeutics 05/2021 - 12/2017
1	Immunotherapy 01/2021